<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Baldwin JG</submitter><funding>Joachim Herz Foundation</funding><funding>German Research Foundation</funding><funding>Ministry of Health</funding><funding>Else Kroner-Fresenius Foundation</funding><funding>National Institutes of Health</funding><funding>Cancer Research Institute</funding><funding>European Innovation Council</funding><funding>European Research Council</funding><funding>Federal Ministry of Education and Research Bonn Office</funding><funding>Fondazione AIRC per la ricerca sul cancro ETS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>Australian American Educational Foundation</funding><pagination>6614-6630.e21</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11623344</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>187(23)</volume><pubmed_abstract>Mitochondrial loss and dysfunction drive T cell exhaustion, representing major barriers to successful T cell-based immunotherapies. Here, we describe an innovative platform to supply exogenous mitochondria to T cells, overcoming these limitations. We found that bone marrow stromal cells establish nanotubular connections with T cells and leverage these intercellular highways to transplant stromal cell mitochondria into CD8&lt;sup>+&lt;/sup> T cells. Optimal mitochondrial transfer required Talin 2 on both donor and recipient cells. CD8&lt;sup>+&lt;/sup> T cells with donated mitochondria displayed enhanced mitochondrial respiration and spare respiratory capacity. When transferred into tumor-bearing hosts, these supercharged T cells expanded more robustly, infiltrated the tumor more efficiently, and exhib</pubmed_abstract><journal>Cell</journal><pubmed_title>Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy.</pubmed_title><pmcid>PMC11623344</pmcid><funding_grant_id>957502</funding_grant_id><funding_grant_id>R01 CA135242</funding_grant_id><funding_grant_id>R01 CA293908</funding_grant_id><funding_grant_id>725038</funding_grant_id><funding_grant_id>R01 CA276525</funding_grant_id><pubmed_authors>Inverso D</pubmed_authors><pubmed_authors>Raimondi A</pubmed_authors><pubmed_authors>Higgs BW</pubmed_authors><pubmed_authors>Rana N</pubmed_authors><pubmed_authors>Gebhard C</pubmed_authors><pubmed_authors>Telford WG</pubmed_authors><pubmed_authors>Baldwin JG</pubmed_authors><pubmed_authors>Iannacone M</pubmed_authors><pubmed_authors>Mastrogiovanni F</pubmed_authors><pubmed_authors>Rehli M</pubmed_authors><pubmed_authors>Sengupta S</pubmed_authors><pubmed_authors>Gautam S</pubmed_authors><pubmed_authors>Slavkovic-Lukic D</pubmed_authors><pubmed_authors>Strieder N</pubmed_authors><pubmed_authors>Barden M</pubmed_authors><pubmed_authors>Martin-Santos A</pubmed_authors><pubmed_authors>Frischholz S</pubmed_authors><pubmed_authors>Gattinoni L</pubmed_authors><pubmed_authors>Schober K</pubmed_authors><pubmed_authors>Fioravanti J</pubmed_authors><pubmed_authors>Kapoor V</pubmed_authors><pubmed_authors>Kontarakis Z</pubmed_authors><pubmed_authors>Saha T</pubmed_authors><pubmed_authors>Schelker RC</pubmed_authors><pubmed_authors>Corn JE</pubmed_authors><pubmed_authors>Beckhove P</pubmed_authors><pubmed_authors>Xydia M</pubmed_authors><pubmed_authors>Brohawn P</pubmed_authors><pubmed_authors>Heuser-Loy C</pubmed_authors><pubmed_authors>Hernandez-Lopez I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy.</name><description>Mitochondrial loss and dysfunction drive T cell exhaustion, representing major barriers to successful T cell-based immunotherapies. Here, we describe an innovative platform to supply exogenous mitochondria to T cells, overcoming these limitations. We found that bone marrow stromal cells establish nanotubular connections with T cells and leverage these intercellular highways to transplant stromal cell mitochondria into CD8&lt;sup>+&lt;/sup> T cells. Optimal mitochondrial transfer required Talin 2 on both donor and recipient cells. CD8&lt;sup>+&lt;/sup> T cells with donated mitochondria displayed enhanced mitochondrial respiration and spare respiratory capacity. When transferred into tumor-bearing hosts, these supercharged T cells expanded more robustly, infiltrated the tumor more efficiently, and exhib</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-06T16:03:35.029Z</modification><creation>2026-06-02T03:11:38.656Z</creation></dates><accession>S-EPMC11623344</accession><cross_references><pubmed>39276774</pubmed><doi>10.1016/j.cell.2024.08.029</doi></cross_references></HashMap>